Building business partnerships in human and animal health

Parties with an interest to tackle major challenges related to infectious diseases in both humans and animals, in collaboration with appropriate business partners, turn to Immuno Valley. We effectively match business and science to specifically build, nurture, and support lasting business partnerships for R&D. Read more about How We Work>

Contact us

Interested in Immuno Valley Network or Services? 
Call us: +31 (0) 30 253 1142
Send an email:



  1. €29m research grant to assess risk posed by deadly lung infections

    An international research consortium RESCEU, with UMC Utrecht as one of the partners, has received a European research grant of € 29 million Euros to study deadly lung infections cause by the respiratory syncytial virus (RSV). The infection occurs mainly in babies and elderly, in recent years Dutch children ICU's in had a high number of patients from the annual RSV epidemic. Read more...

  2. Dissertation: Cell cultures may require fewer laboratory animal experiments for testing vaccines

    Dutch government policy is to reduce the use of animal experiments in biomedical research. In her dissertation, Marieke Hoonakker proved that cell cultures can be used as part of the quality control process for vaccines, at least in the case of whooping cough vaccines. Her research is a step towards the reduction and replacement of animal experiments. Read more...

  3. Antibiotic resistance just became more complex

    Bacteria that are susceptible to antibiotics can survive when enough resistant cells around them are expressing an antibiotic-deactivating factor. This new take on how the microbial context can compromise antibiotic therapy was published by a team of microbiologists from the University of Groningen, together with colleagues from San Diego, in the journal PLOS Biology on 27 December 2016. Read more...

More news


  1. Microbiome Drug Development Summit

    Develop the Current and Future Generations of Microbiome Therapeutics Through Translation of Disease Mechanistic Understanding.

  2. Innnovation for Health

    Innovation for Health is the premier event on healthcare innovations in the Netherlands.

  3. 10th Berlin Conference on Life Sciences: Novel Antimicrobials

    Over its ten-year history, the Berlin Conference on Life Sciences has become a must-attend event for Life Science decision makers, business developers, investors and legal experts. The upcoming conference will explore the exciting market and challenging conditions for the development of novel antimicrobials.

  4. Bio Europe Spring 2017

    The premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe's most innovative biopharma clusters.